openPR Logo
Press release

Idiopathic Pulmonary Fibrosis (IPF) Market 2019 Insights: by Size, Trends, Opportunities, Major Market, Key Players, Upcoming Therapies, Pipeline, Drivers & Barriers Analysis and 2028 Industry Forecast Research Report

07-23-2019 11:19 AM CET | Health & Medicine

Press release from: Mart Research

/ PR Agency: Mart Research
Idiopathic Pulmonary Fibrosis (IPF) Market Insights Research Report

Idiopathic Pulmonary Fibrosis (IPF) Market Insights Research Report

Idiopathic Pulmonary Fibrosis (IPF) Market Insights, Epidemiology and Market Forecast-2028 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of IPF in the United States, Canada, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Idiopathic Pulmonary Fibrosis from 2017 to 2028 segmented by eight major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Geography Covered
- The United States
- Canada
- EU5 (Germany, France, Italy, Spain and the United Kingdom
- Japan
Study Period: 2017-2028

Request a sample report of Idiopathic Pulmonary Fibrosis (IPF) Market Insights Research Report @ https://martresearch.com/contact/request-sample/2/39277

Idiopathic Pulmonary Fibrosis (IPF) Disease Understanding and Treatment Algorithm
The Idiopathic Pulmonary Fibrosis (IPF) Market report gives the thorough understanding of the Idiopathic Pulmonary Fibrosis by including details such as disease definition, staging, symptoms, pathophysiology, and diagnostic trends. It also provides treatment algorithms and treatment guidelines for etiology in the US, Europe, and Japan.

Idiopathic Pulmonary Fibrosis (IPF) Epidemiology
The Idiopathic Pulmonary Fibrosis (IPF) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every eight major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total prevalent diagnosed cases, severity-specific prevalent cases and gender and age -specific prevalent cases) scenario of Idiopathic Pulmonary Fibrosis (IPF) in the G8 covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom), Canada, and Japan from 2017-2028.
Total prevalent population of Idiopathic Pulmonary Fibrosis (IPF) in G8 markets was found to be 229,170 in 2017.

Idiopathic Pulmonary Fibrosis (IPF) Drug Chapters
This segment of the IPF Drug report encloses the detailed analysis of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs and biosimilars. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, and the latest news and press releases.
At present, therapeutic approach of IPF involves both non-pharmacological and pharmacological strategies. Non-pharmacological approach include supplemental oxygen therapy, pulmonary rehabilitation, mechanical ventilation and palliative care services. While the pharmacological treatment options include corticosteroids, immunosuppressive/cytotoxic agents (azathioprine, cyclophosphamide) and anti-fibrotic agents (e.g., colchicine or d-penicillamine) alone or in combination. At present two therapies have obtained approval for treatment of IPF that include antifibrotic drugs (Pirfenidone and Nintedanib). Detailed chapter for upcoming therapies like Thrombomodulin Alfa (Asahi Kasei Pharma Corporation), Pamrevlumab (FibroGen), KD025 (Kadmon Corporation, LLCs) etc. and other promising therapies such as CC-90001 (Celgene Corporation), LT1001 (LTT Bio-Pharma), BG00011 (Biogen Inc) etc. have also been covered in the report.

Idiopathic Pulmonary Fibrosis (IPF) Market Insights Outlook Research Report
The IPF market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
This segment gives a through detail of market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criterias, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
The market of Idiopathic Pulmonary Fibrosis in 8G was found to be USD 1644.4 million in 2017.

Browse the Full Idiopathic Pulmonary Fibrosis (IPF) Market Insights Research Report @ https://martresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-(ipf)-market-insights,-epidemiology-and-market-forecast/2/39277

Idiopathic Pulmonary Fibrosis (IPF) Drugs Uptake
This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2017-2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.
This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Table of Content for Idiopathic Pulmonary Fibrosis (IPF) Market Insights Research Report
Chapter One: Key Insights
Chapter Two: Idiopathic Pulmonary Fibrosis (IPF) Market Overview at a Glance
Chapter Three: Disease Background and Overview: Idiopathic Pulmonary Fibrosis (IPF)
Chapter Four: Epidemiology and Patient Population
Chapter Five: Current Treatment Practices
Chapter Six: Unmet Needs
Chapter Seven: Marketed Products
Chapter Eight: Emerging Therapies
Chapter Nine: Other Promising Candidates
Chapter Ten: Idiopathic Pulmonary Fibrosis (IPF) Market Analysis
Chapter Eleven: Market Drivers of Idiopathic Pulmonary Fibrosis (IPF)
Chapter Twelve: Market Barriers of Idiopathic Pulmonary Fibrosis (IPF)

To Buy Idiopathic Pulmonary Fibrosis (IPF) Market Insights Research Report @ https://martresearch.com/paymentform/2/39277/Single_User

Mart Research
sales@martresearch.com
+1-857-300-1122
Lohgaon, Pune

About us: Research is and will always be the key to success and growth for any industry. Most organizations invest a major chunk of their resources viz. time, money and manpower in research to achieve new breakthroughs in their businesses. The outcome might not always be as expected thereby arising the need for precise, factual and high-quality data backing your research. This is where MART RESEARCH steps in and caters its expertise in the domain of market research reports to industries across varied sectors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Idiopathic Pulmonary Fibrosis (IPF) Market 2019 Insights: by Size, Trends, Opportunities, Major Market, Key Players, Upcoming Therapies, Pipeline, Drivers & Barriers Analysis and 2028 Industry Forecast Research Report here

News-ID: 1809206 • Views: 146

More Releases from Mart Research

Financial Analytics Market 2019: Demand, Type, Size, Applications, Share, Global …
Mart Research new study, Global Financial Analytics Market Report cover definite aggressive standpoint including the piece of the overall industry & profiles of the key members working in the worldwide market. Analytics, enterprise decision management, descriptive analytics, cognitive analytics, Big Data Analytics, retail analytics, supply chain analytics. The global Financial Analytics market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Financial Analytics Product
Financial Smart Cards Market 2019: Demand, Type, Size, Applications, Share, Glob …
Mart Research new study, Global Financial Smart Cards Market Report cover definite aggressive standpoint including the piece of the overall industry & profiles of the key members working in the worldwide market. Financial Smart Cards include identification, financial, mobile phones (SIM), public transit, computer security, schools, and healthcare. Smart cards may provide strong security. Some widely used contactless smart cards include Melbourne's myki, Sydney's Opal Card, London's Oyster card, South
Global Reinsurance Market Size, Share, Growth Rate, Revenue, Applications, Indus …
Mart Research new study, Global Reinsurance Market Report cover definite aggressive standpoint including the piece of the overall industry & profiles of the key members working in the worldwide market. Reinsurance, also known as insurance for insurers or stop-loss insurance, is the practice of insurers transferring portions of risk portfolios to other parties by some form of agreement to reduce the likelihood of paying a large obligation resulting from an
Global Rehabilitation Robots Market Overview 2019, Size, Share, Growth Rate, Maj …
Rehabilitation Robots Market: Shares, Strategy, and Forecasts, Worldwide, 2019 to 2025. The 2019 study has 564 pages, 269 tables and figures. Worldwide Rehabilitation Robot markets are expected to achieve significant growth as robots replace much of the human work in physical therapy. The robots are steadier, make fewer mistakes, support treatment for longer durations, and decrease the cost of rehabilitation for many conditions. The robots permit a more accurate rehabilitation routine

All 5 Releases


More Releases for IPF

Global Contrast Sensor Market 2025 | BALLUFF(Germany), CONTRINEX(Swizerland), Di …
Researchmoz added Most up-to-date research on "Global Contrast Sensor Market Insights, Forecast to 2025" to its huge collection of research reports. The Contrast Sensor market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the
Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
The study analyzed that the IPF pipeline comprised of 104 drug candidates, of which 19 drugs are in the Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. There are various drugs that are being developed as novel and promising therapeutics for the treatment of IPF. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market As per the findings of research, it
Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market US$ 3.5 Billion by 2 …
The global idiopathic pulmonary fibrosis treatment market expected to reach US$ 3.5 billion by 2021, growing at CAGR 14.4% over the forecast period 2017-2021, owing to increasing drug prices and rapid approval of new treatments. Visit Idiopathic Pulmonary Fibrosis (IPF) Treatment Market by Treatment Type - Pharmacological Treatment (Pirfenidone (Esbriet), Nintedanib (Ofev), Generic Pirfenidone); Non-pharmacological Treatment (Oxygen Therapy, Pulmonary Rehabilitation, Mechanical Ventilation, Lung Transplantation, Other Non-Pharmacological Treatment); Patients by Disease Severity
Recent Release: Global Idiopathic pulmonary fibrosis (IPF) Market To 2023
MarketResearchReports.Biz presents this most up-to-date research on "Idiopathic pulmonary fibrosis (IPF)- Epidemiology Forecast To 2023" Idiopathic pulmonary fibrosis (IPF) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Idiopathic pulmonary fibrosis (IPF) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Idiopathic pulmonary fibrosis (IPF) prevalent or incident cases segmented by age, sex and
Idiopathic Pulmonary Fibrosis (IPF) Pipeline, A Novel Advancement for the Treatm …
The study analyzed that the IPF pipeline comprised of 97 therapeutic candidates, of which 15 are in Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. Various drugs are being developed as novel and promising therapeutics for the treatment of IPF. Browse the Report Summary at: www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market Insights on pipeline segments As per the findings of research, it was found
Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology and Market F …
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology